Inventors at the UA Libraries have developed a new e-learning platform for creating easy-to-build tutorials, teaching users how to use web-based tools. The University has licensed the software to startup Sidecar Learning.

Did you know that the UA is Water Resources Program is ranked #1 by the Shanghai Rankings of World Universities? UA inventors have developed a number of promising solutions that are ready for companies to adopt. Check them out.

Startup GenetiRate – founded on an invention out of the College of Agriculture & Life Sciences – is one of two companies honored with the Seafood Innovation Award at the North Atlantic Seafood Forum (NASF) 2019.

At its 32nd Annual IMPACT Awards, the Phoenix GPC awarded the honor to the startup founded on inventions developed at the College of Optical Sciences.

As rats have been nibbling at the edges of society, UA researchers were developing a non-reproductive rodent model for studying menopause. That work yielded a humane, non-lethal rodent infertility formulation, now being commercialized by startup SenesTech.

Funded by the National Eye Institute in the National Institutes of Health, the National Science Foundation, and Tech Launch Arizona, Jim Schwiegerling, PhD, professor at the University of Arizona College of Optical Sciences has developed a series of lenses that might shorten your trip to the eye doctor.

In the lab of Louise Hecker, PhD, researchers have invented the first highly selective Nox4 small molecule inhibitors for the treatment of fibrotic disorders. The UA has licensed the technology to startup Fibronox to bring the invention to the public.

Six teams went head-to-head during a shark tank-style competition hosted by the College of Medicine – Tucson. For their work to reduce asthma attacks, Monica Kraft, MD, and Julie Ledford, PhD, were named the competition winners.

Last year, the drivers behind startup SinfoniaRx announced the launch of UAVenture Capital to support commercialization at the UA. Now, they are announcing a second fund targeting $100 million to further the advance of UA innovations.

Through TLA, the University of Arizona is partnering with Kerafast to license reagents that offer the opportunity for the development of a rapid, highly sensitive diagnostic test for Cryptosporidiosis, the leading cause of waterborne diseases among people in the U.S.